期刊文献+

沙巴棕提取物对肺癌细胞增殖抑制及促凋亡的实验研究 被引量:1

Experimental study of effects of S. repens extract on lung carcinoma cell proliferation inhibition and apoptosis-promoting
下载PDF
导出
摘要 目的观察沙巴棕提取物与人肺癌细胞增殖和凋亡之间的关系,并探索其作用机制。方法应用MTT比色法、流式细胞仪法观察人类肺癌细胞成活、凋亡情况。应用Western blot法观察PARP、CASP3、P27、CDKN1B、p-STAT3蛋白的表达情况。结果沙巴棕提取物以剂量依赖性的方式抑制了肺癌细胞的增殖,并通过上调PARP、CASP3、P27等凋亡相关蛋白促进凋亡。沙巴棕提取物降低了p-STAT3水平;STAT3磷酸化的一种选择性抑制剂———AG490,同样通过降低p-STAT3的水平而抑制了肺癌细胞的生长。相比于以上二者任意一种的单独治疗,沙巴棕提取物和AG490的联合治疗显著降低了肿瘤细胞的增殖(P<0.05)。结论沙巴棕提取物可通过促进凋亡信号和下调p-STAT3蛋白而抑制肺癌细胞增殖。这些观察可能为沙巴棕提取物诱导肿瘤生长抑制的机制研究提供有价值的参考。 Objective To investigate the association between S. repens extract treatment and proliferation and apoptosis of human lung cancer cells, in order to explore the potential mechanism. Methods Cell proliferation of H520 and A549 human lung cancer cells were measured by MTT assay. Cell apoptosis was assessed by flow cytometry. The protein expressions of PARP, CASP3, P27, CDKN1B and p-STAT3 were measured by Western blot. Results S. repens extract suppressed the proliferation of H520 and A549 cells in a dose-dependent manner. S. reperts extract promoted the apoptosis of glioma cells by up-regulating expression of apoptosis-related proteins, including PARP, CASP3 and P27. Moreover, S. repens extract reduced the level of p-STAT3. A selective inhibitor of STAT3 phosphorylation, AG490, also suppressed lung cancer cell growth by downregulating p-STAT3 expression. The combined administration of S. reperts extract and AG490 significantly decreased cell proliferation compared with either treatment alone (P 〈 0.05). Conclusion S. repens extract may suppress lung cancer cell proliferation by promoting apoptosis signaling and down-regulating p-STAT3. These observations may provide valuable reference into the mechanism study of S. repens extract-induced tumor growth inhibition.
出处 《中国医药导报》 CAS 2013年第13期6-10,共5页 China Medical Herald
基金 国家自然科学基金资助项目(编号81102029)
关键词 沙巴棕提取物 肺癌 生长抑制 信号传导与转录激活因子 凋亡 Serenoa repens extract Lung cancer cell Growth inhibition STAT3 Apoptosis
  • 相关文献

参考文献22

  • 1廖美琳,高玉堂.上海市区人群中肺癌病员预后因素的研究[J].中华结核和呼吸杂志,1993,16(1):36-38. 被引量:24
  • 2Non-small Cell Lung Cancer Collaborative Group. Chemo therapy in non-small cell lung cancerameta-analysis using updated data on in- dividual patients from 52 randomized clinical trials [J]. BMJ, 1995,311 (7010) : 899-909.
  • 3Arriagada R,Bergman B, Dunanta,et al. Cisplatin -based adjuvant chemotherapy in patientswith completely resected non-small cell lung cancer [J]. N Eng J Med,2004,350(4) :351-360.
  • 4Winton TL, Livingston R,Johnson D,et al. A prospective randomized trial of adjuvant vinorelbine (VIN)and cisplatin (CIS)in completely resected stage B and non small cell lung cancer (NSCLC)Intergroup JBR. 10 [J]. ProcASCO,2004,23(Abstr7018) :17.
  • 5Sraussg M,Hemdon J,Maddausm A,et al. Randomized Clinical Tri- alofadjuvant chemo therapy with paclitaxeland arboplatin following resection in stage NB non-small cell lung cancer(NSCLC). Report of Cancer and Leukemia Group B (CALGB)Protocol 9633 [J]. ProcAS- CO, 2004,23 (Abstr7019 ) : 17.
  • 6Rahaman SO, Harbor PC, Chemova O, et al. Inhibition of constitutive- ly active STAT3 suppresses proliferation and induces apoptosis in glioblastoma muhiforme cells [J]. Oncogene, 2002,21 (55) : 8404-8413.
  • 7Cassilethal B. Integrative oncalogy. Saw palmetto [J]. Oncology,2010,24 (8) :766.
  • 8Iguchi K,Okumura N,Usui S,et al. Myristoleic acid, a cytotoxic component in the extract from Serenoa repens,induces apoptosis and necrosis in human prostatic LNCaP cells [J]. Prostate,2001,47 ( 1 ) : 59-65.
  • 9Vacherot F,Azzouz M,Gil-Diez-De-Medin S,et al. Raynaud JP and Chopin DK:Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (I_SESr,Permixon)in benign prostatic hyperplasia [J]. Prostate, 2000,45 (3) : 259-266.
  • 10Goldmann WH, Sharma AL, Currier S J, et al. Saw palmetto berry ex- tract inhibits cell growth and Cox-2 expression in prostatic cancer cells [J]. Cell Biol Int, 2001,25 ( 11 ) : 1117-1124.

二级参考文献14

  • 1廖美琳,中华结核和呼吸杂志,1990年,13卷,141页
  • 2廖美琳,中华肿瘤杂志,1988年,10卷,34页
  • 3徐昌文,中华结核和呼吸杂志,1983年,6卷,368页
  • 4团体著者,肿瘤,1982年,3卷,3页
  • 5Opdam FJ, Kamp M, Bruijn R, et al. Jak kinase activity is required for lymphoma invasion and metastasis. Oncogene,2004, 23: 6647-6653.
  • 6Patel NJ, Hansen A, Merati AL, et al. STAT3 activation in recurrent respiratory papillomatosis. Areh Otolaryngol Head Neck Surgery, 2004, 130: 1043-1045.
  • 7Weissenberger J, Loeffler S, Kappeler A. IL-6 is required for glioma development in a mouse model. Oncogene, 2004, 23:3308-3316.
  • 8Kanda N, Seno H, Konda Y. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene, 2004, 23: 4921-4929.
  • 9Niwa Y, Kanda H, Shikauchi Y, et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.Oncogene, 2005, 24: 6406-6417.
  • 10Eriksen KW, Kaltoft K, Mikkelsen G, et al. Constitutive STAT3-aetivation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia, 2001, 15: 787-793.

共引文献32

同被引文献12

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部